Overview

Global Active Pharmaceutical Ingredient Market is estimated to value over USD 240.1 billion by 2026 end and register a CAGR of over 5.9% during the forecast period 2019 to 2026.

An abundance of capital is needed for the production of API, as the procedures require very systematic and precise protocols. As a result, there is no focus on physical manpower and setting up of costly manufacturing units. By adopting tactful and strategic outsourcing, the companies can emphasize more on their competencies, thereby, culminating in heightened productivity.

Active pharmaceutical ingredients (APIs) which have good quality, are crucial for the production of safe and effective medicines. However, it should be noted that not all pharmaceutical companies have adopted their own individual API manufacturing units. According to the market analysis, the rise of ailments such as cardiovascular and periodontal diseases, back pain, cancer and dental caries are factors which are expected to propel the active pharmaceutical ingredients market growth. The need for affordable medication and the rise in the volume of ANDA filings is projected to augment the market.

The acceptance of biologics and biosimilars and the rise in ailments such as cancer and chronic diseases, are factors which have been predicted to drive the market. However, aspects such as strict regulatory bodies and intense competition among other players, coupled with issues relating to price control regulations are all likely to pose potential threats to the market growth

Going by the product type, the market is divided into innovative and generic APIs. Innovative drugs segment is expected to rise owing to relaxed government rules and regulations. The segment for generic drugs is anticipated to grow in the future because of the affordability and patent expiry of branded drugs. This segment is predicted to expand in the developing nations owing to the untreated medical needs and rapid adoption of over-the-counter drugs.

With the type of manufacturer, the market is classified into merchant and captive APIs.

Captive API segment holds much strength in the market because of capitalist oriented focus with companies active in the production of availability of raw materials and top-of-the- line manufacturing facilities. With merchant API segment, it is forecasted to be a thriving segment precisely because of a growing need for biopharmaceuticals and exorbitant cost of in-house production of molecules. Moreover, because the captive production of APIs is costly, companies have begun to look to outsourcing to cut back on costs.

The biotech type is then categorized recombinant proteins, vaccines and antibodies. Synthetic segment has captured significant market share due to easy accessibility of raw materials, an abundance of revenue shares and relatively easy process of synthesis. Application-wise, the market is broken down into oncology, cardiology, endocrinology and neurology. The cardiology sub-segment has seen a spur in the market because of illnesses such as stroke and heart attack.

 

Some major global players in the APIs market include Sanofi (France), Teva Pharmaceutical Industries Ltd. (Israel), AbbVie Inc. (US), Pfizer, Inc. (US), Boehringer Ingelheim (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), GlaxoSmithKline plc (UK), Novartis AG (Switzerland), Merck & Co., Inc. (US), Bristol-Myers Squibb (US), AstraZeneca plc (UK), Eli Lilly and Company (US).

Active Pharmaceutical Ingredient Market

Active Pharmaceutical Ingredient Market Segmentation:

By Type   

  • Innovative Active Pharmaceutical Ingredients
  •  Generic Active Pharmaceutical Ingredients 

By Type of Manufacturer

  • Captive API Manufacturers
  • Merchant API Manufacturers

 By Type

~ Merchant Innovative API Manufacturers

~ Merchant Generic API Manufacturers                

           By Type of Synthesis

 ~ Merchant Synthetic API Manufacturers

~ Merchant Biotech API Manufacturers

By Type of Synthesis

  • Synthetic Active Pharmaceutical Ingredients

- Innovative Synthetic APIS

- Generic Synthetic APIS        

  • Biotech Active Pharmaceutical Ingredients

           By Type

~  Innovative Biotech APIS

~  Generic Biotech APIS  

           By Product

~  Monoclonal Antibodies

~  Hormones & Growth Factors

~  Cytokines

~  Fusion Proteins

~  Recombinant Vaccines

  Therapeutic Enzymes

  Blood Factors

By Expression System

~ Mammalian Expression Systems

~ Microbial Expression Systems

~ Yeast Expression Systems

~ Insect Expression Systems

~ Other Expression Systems

By Type of Drug

  •   Prescription Drugs
  •   Over-The-Counter Drugs

By Potency

  •     Low-To-Moderate Potency Active Pharmaceutical Ingredients
  •     Potent-To-Highly Potent Active Pharmaceutical Ingredients

By Therapeutic Application

  •    Communicable Diseases
  •    Oncology  
  •    Pain Management
  •    Cardiovascular Diseases
  •    Diabetes
  •    Respiratory Diseases
  •    Other Therapeutic Applications

By Region                                                                            

  • North America
  • Europe
  • Asia- Pacific
  • World                                                                         

 

FutureWise Key Takeaways:

  •     Growth prospects
  •     SWOT analysis
  •     Key trends
  •     Key data-points affecting market growth

 

Objectives of the Study:

  • To provide with an exhaustive analysis on the active pharmaceuticals market by type, by manufacturer, by type of synthesis, by product, by type of drug, by potency, by therapeutic application and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, industry-specific restraints and opportunities)
  • To forecast and evaluate micro-markets and the overall market 
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and the rest of the world 
  • To record, evaluate and analyse competitive landscape mapping- technological advancements, product launches, expansions and mergers 

$3450

Need Assistance

--------

UK : +44 141 628 9353
US : +1 347 709 4931

OR

Contact Sales

What you get


  • Excel Dataset

  • Infographics

  • PDF Report

  • Market Overview

  • PowerPoint Presentation

What's included


  • Consumer Perception and Procurement

  • Competitive Analysis

  • What’s Next

  • Market Data Forecast

  • Risks and Opportunity Assessment

  • Market Trends and Dynamics